Subclinical atherosclerosis in Behcet’s disease and its inverse relation to azathioprine use: an updated meta-analysis

[1]  G. Hatemi,et al.  Vascular Behçet syndrome: from pathogenesis to treatment , 2022, Nature Reviews Rheumatology.

[2]  Hua Chen,et al.  Macrophage polarization toward M1 phenotype through NF-κB signaling in patients with Behçet’s disease , 2022, Arthritis Research & Therapy.

[3]  A. Radwan,et al.  Exists a role for serum irisin in Egyptian Behcet’s patients with subclinical atherosclerosis? , 2022, Clinical Rheumatology.

[4]  M. Casula,et al.  Colchicine for cardiovascular medicine: a systematic review and meta-analysis. , 2022, Future cardiology.

[5]  A. Kucuk,et al.  Proprotein convertase subtilisin/kexin type 9 is associated with atherosclerosis in patients with Behcet’s disease , 2022, Clinical and experimental hypertension.

[6]  M. Hussein,et al.  Interleukin 37; a possible marker of arterial stiffness in Behçet's disease. , 2022, The American journal of the medical sciences.

[7]  P. Demelo-Rodríguez,et al.  Arterial and venous involvement in Behçet’s syndrome: a narrative review , 2022, Journal of Thrombosis and Thrombolysis.

[8]  R. Levy,et al.  Evaluation of endothelial function in patients with Behçet's disease in remission: A cross-sectional study. , 2022, European Journal of Rheumatology.

[9]  F. Gentile,et al.  Plasma Homocysteine in Behcet's Disease: A Systematic Review and Meta-Analysis , 2022, Thrombosis and Haemostasis.

[10]  A. Arcangeli,et al.  A unique circulating miRNA profile highlights thrombo-inflammation in Behçet’s syndrome , 2021, Annals of the Rheumatic Diseases.

[11]  A. Ateş,et al.  Analysis of vascular involvement in 460 patients with Behçet's syndrome: Clinical characteristics and associated factors. , 2021, Joint bone spine.

[12]  A. Jawień,et al.  New insight into biology, molecular diagnostics and treatment options of unstable carotid atherosclerotic plaque: a narrative review , 2021, Annals of translational medicine.

[13]  Susan Cheng,et al.  Age of Hypertension Onset: Overview of Research and How to Apply in Practice , 2020, Current Hypertension Reports.

[14]  M. Kawashiri,et al.  What is the mechanism of genetic contributions to the development of atherosclerosis? , 2020, Atherosclerosis.

[15]  Ahmed A. Elsammak,et al.  Association between serum homocysteine and arterial stiffness in patients with Behçet’s disease , 2020, The Egyptian Rheumatologist.

[16]  K. Raza,et al.  Epidemiology, morbidity and mortality in Behçet's disease: a cohort study using The Health Improvement Network (THIN). , 2020, Rheumatology.

[17]  G. Hatemi,et al.  Behçet's Syndrome as a Model of Thrombo-Inflammation: The Role of Neutrophils , 2019, Front. Immunol..

[18]  S. Humphries,et al.  Polygenic Hypercholesterolemia and Cardiovascular Disease Risk , 2019, Current Cardiology Reports.

[19]  Heather B. Blunt,et al.  PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews , 2021, Systematic Reviews.

[20]  E. Seyahi.  Phenotypes in Behçet’s syndrome , 2019, Internal and Emergency Medicine.

[21]  N. Kocer,et al.  Assessment of the common carotid artery wall stiffness by Shear Wave Elastography in Behcet's disease. , 2018, Medical ultrasonography.

[22]  R. Fawzy,et al.  Neutrophil-to-lymphocyte ratio: relation to disease activity and carotid intima-media thickness in Behçet’s disease , 2018, Egyptian Rheumatology and Rehabilitation.

[23]  P. Youinou,et al.  Increased IL-1β levels are associated with an imbalance of “oxidant/antioxidant” status during Behçet’s disease , 2018, European Cytokine Network.

[24]  A. Aslan,et al.  Investigation of the arterial intima-media thickness in Behcet’s disease patients without vascular complaints , 2018, Vascular.

[25]  S. Upala,et al.  Increased Arterial Stiffness in Behçet's Disease: a Systematic Review and Meta-Analysis , 2017, Korean circulation journal.

[26]  H. Fathi,et al.  Clinical significance of metabolic syndrome and carotid intima-media thickness in Behҫet’s disease patients: Relation to disease activity , 2017 .

[27]  S. Yolbaş,et al.  Carotid artery stiffness in Behçet's disease. , 2017, European journal of rheumatology.

[28]  Ş. Arslan,et al.  Atherogenic index of plasma may be strong predictor of subclinical atherosclerosis in patients with Behçet disease , 2017, Zeitschrift für Rheumatologie.

[29]  J. Fareed,et al.  Patients With a History of Idiopathic Deep Venous Thrombosis Have Long-Term Increased Levels of Inflammatory Markers and Markers of Endothelial Damage , 2017, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[30]  E. Dagistan,et al.  Extra‐medial thickness of carotid artery in patients with Behçet's disease: evaluation of atherosclerotic vessel wall changes with a novel carotid artery ultrasound index , 2016, International journal of dermatology.

[31]  R. Bender,et al.  Performance of the Peto odds ratio compared to the usual odds ratio estimator in the case of rare events , 2016, Biometrical journal. Biometrische Zeitschrift.

[32]  E. Seyahi.  Behçet's disease: How to diagnose and treat vascular involvement. , 2016, Best practice & research. Clinical rheumatology.

[33]  Ş. Arslan,et al.  Novel myokine: irisin may be an independent predictor for subclinic atherosclerosis in Behçet's disease , 2016, Journal of Investigative Medicine.

[34]  I. Ster,et al.  Subclinical atherosclerosis in Behcet's disease: A systematic review and meta-analysis. , 2016, Seminars in arthritis and rheumatism.

[35]  Belkız Uyar,et al.  Evaluation of Arterial Stiffness in Patients with Behçet's Disease by Using Noninvasive Radiological Methods such as Intima-Media Thickness of the Carotid, Ankle-Brachial Pressure Index, Coronary Artery Calcium Scoring, and Their Relation to Serum Fetuin-A Levels: A Case-Control Study , 2015, Annals of dermatology.

[36]  Sun Park,et al.  Increased expression of the NLRP3 inflammasome components in patients with Behçet’s disease , 2015, Journal of Inflammation.

[37]  J. Piette,et al.  Ethnicity and association with disease manifestations and mortality in Behçet’s disease , 2014, Orphanet Journal of Rare Diseases.

[38]  L. Bortolotto,et al.  Increased arterial stiffness assessed by pulse wave velocity in Behçet’s disease and its association with the lipid profile , 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.

[39]  Ö. Yıldırımtürk,et al.  Evaluation of endothelial functions in patients with Behcet's disease without overt vascular involvement. , 2012, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.

[40]  J. Piette,et al.  Immunosuppressants reduce venous thrombosis relapse in Behçet's disease. , 2012, Arthritis and rheumatism.

[41]  T. Gheita,et al.  Subclinical Atherosclerosis in Behçet's Disease , 2012 .

[42]  J. Mnif,et al.  Intima-media thickness of carotid artery in patients with Behçet's disease. , 2011, Archives of medical research.

[43]  A. Işık,et al.  Serum adiponectin and vaspin levels in rheumatoid arthritis. , 2010, Archives of medical research.

[44]  Hannah R Rothstein,et al.  A basic introduction to fixed‐effect and random‐effects models for meta‐analysis , 2010, Research synthesis methods.

[45]  Jong Chun Park,et al.  Carotid artery intima-media thickness in Behcet's disease patients without significant cardiovascular involvement , 2008, The Korean journal of internal medicine.

[46]  H. Gullu,et al.  Cardiovascular prognostic value of vascular involvement in Behcet's disease. , 2008, International journal of cardiology.

[47]  S. Oktar,et al.  Vascular endothelial growth factor and carotid intima-media thickness in patients with Behçet’s disease , 2008, Clinical Rheumatology.

[48]  G. Hatemi,et al.  Atherosclerosis in Behçet's Syndrome. , 2008, Seminars in arthritis and rheumatism.

[49]  M. Rhee,et al.  Intima-media Thickness and Arterial Stiffness of Carotid Artery in Korean Patients with Behçet's Disease , 2007, Journal of Korean medical science.

[50]  I. Olkin,et al.  The case of the misleading funnel plot , 2006, BMJ : British Medical Journal.

[51]  S. Oktar,et al.  Morphologic evidence of subclinical atherosclerosis obtained by carotid ultrasonography in patients with Behcet’s disease , 2006, Rheumatology International.

[52]  H. Oflaz,et al.  Impaired endothelium‐dependent flow‐mediated dilation in Behçet's disease: more prominent endothelial dysfunction in patients with vascular involvement , 2005, International journal of clinical practice.

[53]  M. S. Ulgen,et al.  Intima-Media Thickness and Arterial Distensibility in Behçet’s Disease , 2004, Angiology.

[54]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[55]  K. S. Cheon,et al.  The clinical significance of a pathergy reaction in patients with Behcet's disease. , 2002, Journal of Korean medical science.

[56]  A. Silman,et al.  Behçet's disease: evaluation of a new instrument to measure clinical activity. , 1999, Rheumatology.

[57]  OUP accepted manuscript , 2021, European Heart Journal.